EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular and biophysical requirements for B cell receptor-dependent enhancement of dengue virus infection

Gaby Madrigal iD, Chad Gebo iD, Benjamin D McElvany, Menelaos Symeonides, Sean A Diehl iD, Adam T Waickman iD

Journal of Virology · 2026

DOI: 10.1128/jvi.02216-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2026. Verfasst von Gaby Madrigal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Molecular Genetics, University of Vermont Larner College of Medicine, Burlington, Vermont, USA. Hauptthemen laut MEDLINE: Dengue Virus, Dengue, B-Lymphocytes, Antibody-Dependent Enhancement. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dengue virus (DENV) is the causative agent of dengue, a mosquito-borne disease that represents a significant and growing public health burden around the world. A unique pathophysiological feature of dengue is immune-mediated enhancement, wherein preexisting immunity elicited by a primary infection can enhance the severity of a subsequent infection by a heterologous DENV serotype. A leading mechanistic explanation for this phenomenon is antibody-dependent enhancement (ADE), where sub-neutralizing concentrations of DENV-specific IgG antibodies facilitate the entry of DENV into FcγR-expressing cells. Accordingly, this model posits that phagocytic mononuclear cells are the primary reservoir of DENV. However, multiple independent groups have shown that B cells are the largest reservoir of virally infected cells in circulation during acute dengue, representing a disconnect in our understanding of immune-mediated DENV tropism. In response to this persistent knowledge gap, our team has previously identified a novel mechanism of immune-mediated enhancement we have termed B cell receptor (BCR)-dependent enhancement (BDE) of DENV infection. In this study, we show that DENV infection of DENV-reactive B cells is highly sensitive to BCR/DENV envelope (E) protein interactions. DENV entry into this subset of B cells is dynamin-mediated, requires proximal BCR signaling, and involves localization to late endosomes. Finally, we show that immortalized DENV-reactive B cells are productively infected by live DENV, capable of supporting active viral replication of all four serotypes. We propose that BDE provides an additional layer of pathogen-specific immune-mediated infection risk that complements existing models of ADE and offers additional insight into potential mechanisms of DENV immunopathogenesis. IMPORTANCE This study provides mechanistic insight into the process of B cell receptor (BCR)-dependent enhancement of dengue virus (DENV) infection. Immune-mediated enhancement of infection is a cornerstone of dengue immunopathogenesis and is most often attributed to antibody-dependent enhancement (ADE). BCR-dependent enhancement of DENV infection is an alternative and complementary mechanism for immune-mediated enhancement that addresses several persistent knowledge gaps in the dengue field and may offer mechanistic insight into why some people progress to severe dengue after infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dengue VirusDengueB-LymphocytesAntibody-Dependent EnhancementReceptors, Antigen, B-CellHumansAnimalsAntibodies, ViralVirus InternalizationImmunoglobulin G

Stichwörter der Autor:innen

B cellBCRBCR-dependent enhancementDENVdengue virusimmune-mediated enhancement

Substanzen

Receptors, Antigen, B-CellAntibodies, ViralImmunoglobulin G

Autor:innen und Institutionen

  • Department of Microbiology and Molecular Genetics, University of Vermont Larner College of Medicine, Burlington, Vermont, USA.
  • Cellular and Molecular Biomedical Sciences Graduate Program, University of Vermont, Burlington, Vermont, USA.
  • Department of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, New York, USA.
  • Vaccine Testing Center, University of Vermont Larner College of Medicine, Burlington, Vermont, USA.
  • Translational Global Infectious Diseases Research Center, University of Vermont, Burlington, Vermont, USA.
  • Global Health Institute, State University of New York Upstate Medical University, Syracuse, New York, USA.

ORCID-Profile: Gaby Madrigal, Chad Gebo, Sean A Diehl, Adam T Waickman

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institute of General Medical Sciences

Zitieren

APA

Madrigal, G., Gebo, C., McElvany, B. D., Symeonides, M., Diehl, S. A., & Waickman, A. T. (2026). Molecular and biophysical requirements for B cell receptor-dependent enhancement of dengue virus infection. Journal of Virology. https://doi.org/10.1128/jvi.02216-25

Vancouver

Madrigal G, Gebo C, McElvany BD, Symeonides M, Diehl SA, Waickman AT. Molecular and biophysical requirements for B cell receptor-dependent enhancement of dengue virus infection. Journal of Virology. 2026. doi:10.1128/jvi.02216-25

BibTeX
@article{Madrigal2026,
  author = {Madrigal, Gaby and Gebo, Chad and McElvany, Benjamin D and Symeonides, Menelaos and Diehl, Sean A and Waickman, Adam T},
  title = {Molecular and biophysical requirements for B cell receptor-dependent enhancement of dengue virus infection},
  journal = {Journal of Virology},
  year = {2026},
  doi = {10.1128/jvi.02216-25}
}
Kostenlos starten →